Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Cancer Type/Condition:  Cancer- and cancer treatment-related conditions
Stage/Subtype:  neuropathy
Trial Type:  Supportive care
Trial Status:  Active
Results 1-25 of 51 for your search:
Start Over
Omega-3 Fatty Acids and Chemotherapy-induced Neuropathy and Inflammation in Breast Cancer
Phase: Phase IV
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 30 to 65
Sponsor: Other
Protocol IDs: 88-04-27-9683, NCT01049295
A Study to Assess the Efficacy and Safety of Oxycodone/Naloxone in Korean Patients With Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Phase: Phase IV
Type: Supportive care
Status: Active
Age: 20 to 79
Sponsor: Other
Protocol IDs: OXN12-KR-402, NCT01675531
Randomized Placebo-Controlled Trial of Glutamine for Breast Cancer Patients With Peripheral Neuropathy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 0309006308, NCT00195013
Evaluation of Bortezomib Induced Peripheral Neuropathy of Multiple Myeloma (MM) Patients
Phase: Phase III
Type: Natural history/Epidemiology, Supportive care
Status: Approved-not yet active
Age: 18 to 75
Sponsor: Other
Protocol IDs: Version 1.1, NCT00872352
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: RTOG 0724, CDR0000654709, NCI-2011-01973, NCT00980954
Ketamine Hydrochloride and Best Pain Management in Treating Cancer Patients With Neuropathic Pain
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CDR0000696704, CRUK-KPS-2008-01, EU-21012, EUDRACT-2007-002080-27, ISRCTN-49116945, NCT01316744
Prevention of Oxaliplatin-induced Neuropathic Pain by a Specific Diet
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: CHU-0137, 2011-A00911-40, NCT01775449
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: E1A11, NCI-2012-02608, U10CA021115, NCT01863550
Effectiveness of Ketamine in Malignant Neuropathic Pain Relief
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 2012/539, NCT01951911
CORAL - Cebranopadol Versus Morphine Prolonged-release in Patients With Chronic Moderate to Severe Pain Related to Cancer
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: KF6005/07, 2012-001316-35, U1111-1143-1808, NCT01964378
Brentuximab Vedotin and Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed Hodgkin Lymphoma
Phase: Phase III
Type: Biomarker/Laboratory analysis, Health services research, Supportive care, Treatment
Status: Active
Age: 18 and younger
Sponsor: NCI
Protocol IDs: NCI-2014-01223, AHOD1331, NCT02166463
Vit D3 and Omega 3 in Chemo Induced Neuropathy
Phase: Phase III
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 4086, NCT02294149
Acupuncture Chemotherapy-Induced Peripheral Neuropathy (CIPN) IRG
Phase: Phase II, Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-1054, NCI-2014-01520, NCT01815346
SINF: Peripheral Neuropathy in Cancer Survivors
Phase: Phase II, Phase I
Type: Supportive care
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0930, NCI-2014-01466, NCT02168894
Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: CCR3116, NCT01278004
Therapeutic Interventions For Pain Induced By Vincristine Treatment For Childhood Acute Lymphoblastic Leukemia (ALL)
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 1 to 18
Sponsor: Other
Protocol IDs: TINALL, NCT01506453
Characterization and Treatment of Chemotherapy Neuropathy
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: R01CA151692, NCT01557608
The Purpose of This Study is to Determine if Tetrodotoxin (TTX) is Effective in the Treatment of Pain Resulting From Chemotherapy Treatment
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: TTX-CINP-201, NCT01655823
Topical Menthol for the Treatment of Chemotherapy Induced Peripheral Neuropathy
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: AAAL2664, NCT01855607
Phase II Study of Minocycline for Reducing Symptom Burden in Colorectal Patients
Phase: Phase II
Type: Biomarker/Laboratory analysis, Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2013-0323, NCI-2014-01291, RSG-13-241-01-PCSM, NCT01906008
Efficacy of Monosialotetrahexosylganglioside in the Prophylactic Treatment of Bortezomib-induced Peripheral Neuropathy
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GM1, NCT02093910
Prevention of Paclitaxel Neuropathy With Cryotherapy
Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2014.1, NCT02230319
Standard Care Alone or With Acupuncture for CIPN in Metastatic Breast Cancer and Multiple Myeloma
Phase: Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 12_DOG06_165, PB-PG-0213-30129, CFTSp062, NCT02275403
Metformin for Reduction of Paclitaxel-Related Neuropathy in Patients With Breast Cancer
Phase: Phase II
Type: Supportive care
Status: Approved-not yet active
Age: Over 18
Sponsor: Other
Protocol IDs: 2014-0438, NCT02360059
Start Over